Patent law in Europe: What pharmaceutical companies need to know

by Hogan Lovells
Increasing competition within Europe’s pharmaceutical space makes knowing the market and understanding available patent protections more critical than ever for both well established and new market players. Andreas von Falck and Miriam Gundt, partners in Hogan Lovells’ Dusseldorf office, say that companies should consider five key factors influencing patent law across the European market.

1. Europe: a hotspot for patent litigation

Europe has See more +

Increasing competition within Europe’s pharmaceutical space makes knowing the market and understanding available patent protections more critical than ever for both well established and new market players. Andreas von Falck and Miriam Gundt, partners in Hogan Lovells’ Dusseldorf office, say that companies should consider five key factors influencing patent law across the European market.

1. Europe: a hotspot for patent litigation

Europe has seen a steady increase in patent litigation in recent years, a trend Gundt believes is being driven in part by the many litigation options available to patent holders. "Ten years ago, we saw much more patent litigation in the U.S., but now we're seeing a sharp increase across all sectors in Europe," she says. "Europe is a nice ground to litigate patents because companies can make use of the many different jurisdictions and procedural systems within the 27 member states.”

2. European courts are becoming more flexible regarding second medical use claims

“It used to be that second medical use patents, which protect a specific ‘use’ of a pharmaceutical product (e.g. a specific disease or group of patients), could only be infringed when the packaging of the product referred to the specific protected use,” says von Falck. “But many European courts are becoming a bit more flexible, claiming you must consider the overall context of the marketing for the product. This shift may ultimately benefit patentees in enforcing these types of patents. It also means that defendants and generic companies will ultimately need to do more to avoid patent infringement than simply excluding patent-protected information on their labels (also known as ‘skinny labeling’).”

3. The doctrine of equivalence creates additional opportunities and challenges for market players

Von Falck says that the doctrine of equivalence —which says that patent claims can capture infringements beyond the "literal" meaning of a patent claim— continues to serve as a meaningful tool for patentees to achieve appropriate protection in litigation. Landmark cases, like 2017’s Actavis vs Eli Lilly are evidence that the doctrine continues to be relevant. “The pharmaceutical industry is one where the products are so valuable that parties will litigate these cases to the very end,” he says. “The [doctrine of equivalents] is an extra line of defense that can mean longer, more costly proceedings.”

4. Compulsory licenses ensure critical drugs stay on the market

Originally designed to allow generic drugs to enter markets where originators did not make product, compulsory licenses can also serve as a defense for originators. Where claims for injunctive relief are enforced against pharmaceuticals that are important from a public health perspective (such as for the treatment of HIV or cancer) European courts can grant permission for the maker of the pharmaceutical to continue marketing the product against payment of a royalty to be set by the court.

“The rate of compulsory licensing is a reflection of changing market behaviors,” says Gundt. “The temptation to remove a competitive product from the market continues to grow, and compulsory licensing ensures critical drugs stay on the market.”

5. Know the market and plan ahead

“Whether companies are looking to market new products, or they are trying to effectively protect their innovations as a patentee, planning ahead is crucial,” says Gundt. “What that means in practice is that (pharmaceutical companies) need to start preparing three to four years in advance of planned product launches by closely analyzing the competitive environment. The earlier they do that, the better prepared they’ll be to set up an effective (litigation) strategy that serves their interests. (If you wait until) you're already being sued (as the defendant) or your patent is already being infringed, it's definitely too late.”

For more insights from von Falck and Gundt on changing patent trends throughout Europe, watch the video above. See less -


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Hogan Lovells | Attorney Advertising

Written by:

Hogan Lovells

Hogan Lovells on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.